Skip to main content
Caplight Logo









Bullseye Biosciences

Bullseye Biosciences

Private
MassachusettsHealthcare & Life Scienceshttps://www.bullseyebiosciences.com/

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$3M

Company Overview

Bullseye Biosciences is a biotechnology company that operates a therapeutics discovery platform using robotics, directed evolution, and sequencing to develop medicines for oncology, immunology, and cardiometabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discovery platformin-cell directed evolutionundruggable targetsplatform biotechintracellular targetsAI drug discoverymachine learning for drug discoverymacrocyclic peptidesmolecular gluesoncology therapeuticscardiometabolic therapeuticsinflammation therapeuticslab automationnext-generation sequencingNGSpreclinical therapeuticsprotein-protein interactionPPI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bullseye Biosciences Comparables

Compare Bullseye Biosciences with similar companies based on industry and business-model similarity.

Bullseye Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SyntheX
84%
Ambagon Therapeutics
80%
Orbis Medicines
79%

Bullseye Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025

Key People

Founding team and executive leadership

Corey Gray

CEO And Co-Founder

Founding Team

Bullseye Biosciences Investors

Notable investors and investment history

Bullseye Biosciences investors
InvestorRounds
Harvard Innovation LabsSeed
ZAKA VCSeed
Ono Venture Investment, Inc.Accelerator
Mission BioCapitalSeed, Accelerator
National Science FoundationSeed
Illumina VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 100% QoQ from 3 to 6 employees.

  • May 4, 2025

    Monthly visitors increased 407% MoM.

Bullseye Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bullseye Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bullseye Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts
Employee Range5
Year Founded2023
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?